Neurolief secured a US Department of Veterans Affairs contract to bring two prescription neuromodulation therapies to veterans: Proliv Rx for treatment-resistant depression and Relivion MG for acute migraine. Both are non-invasive, self-administered at home under physician supervision, and stimulate branches of the occipital and trigeminal nerves through a head-worn device. The VA is the largest integrated health system in the US, serving nine million veterans, among whom depression and migraine are especially common. In the pivotal depression trial, remission reached 21.3% with active therapy against 6% for sham.